GMU scientists discover cancer resistance signatures using n

Scientists at George Mason University’s Center for Applied Proteomics and Molecular Medicine (CAPMM) developed a new technology for testing breast cancer tumors. They used it to discover “novel proteomic-based signatures

Related Keywords

Rosa Isela Gallagher , Julia Wulfkuhle , Emanuel Petricoin , George Mason , Department Of Defense , Mason Center , Scientists At George Mason University Center , George Mason University , Applied Proteomics , Molecular Medicine , Cell Reports Medicine , Hubble Telescope , Webb Telescope , Theralink Technologies , Health And Food ,